Q2 2023 Holdings
Filed 2023-08-11 | 73 holdings | $807.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| The Cigna Group(CI) | COM | 125523100 | $50.5M | 180,000 | 6.3% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $43.7M | 300,000 | 5.4% |
| Novo-Nordisk A SPut | PUT | 670100955 | $40.5M | 250,000 | 5.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $33.4M | 103,000 | 4.1% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $30.8M | 72,000 | 3.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $25.2M | 466,000 | 3.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $21.2M | 650,000 | 2.6% |
| Cooper COS Inc | COM NEW | 216648402 | $19.9M | 52,000 | 2.5% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $18.9M | 232,000 | 2.3% |
| Revvity Inc(RVTY) | COM | 714046109 | $16.6M | 140,000 | 2.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $15.6M | 40,000 | 1.9% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $15.3M | 300,000 | 1.9% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $14.9M | 220,000 | 1.8% |
| Guardant Health Inc(GH) | COM | 40131M109 | $14.7M | 412,000 | 1.8% |
| Hologic Inc(HOLX) | COM | 436440101 | $14.2M | 175,000 | 1.8% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $14.1M | 30,000 | 1.7% |
| Centene Corp del(CNC) | COM | 15135B101 | $13.5M | 200,000 | 1.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $13.5M | 100,000 | 1.7% |
| Elevance Health Inc(ELV) | COM | 036752103 | $13.3M | 30,000 | 1.7% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $13.2M | 265,000 | 1.6% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $12.7M | 450,000 | 1.6% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $12.5M | 350,000 | 1.5% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $12.3M | 36,000 | 1.5% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $12.2M | 120,000 | 1.5% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $12.1M | 40,000 | 1.5% |
| Danaher Corporation(DHR) | COM | 235851102 | $12.0M | 50,000 | 1.5% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $11.9M | 72,000 | 1.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $11.8M | 730,000 | 1.5% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $11.5M | 350,000 | 1.4% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $11.2M | 250,000 | 1.4% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $10.4M | 103,000 | 1.3% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $10.3M | 445,000 | 1.3% |
| Penumbra Inc(PEN) | COM | 70975L107 | $10.3M | 30,000 | 1.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $9.9M | 52,000 | 1.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $9.5M | 356,000 | 1.2% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $9.0M | 155,000 | 1.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $9.0M | 142,000 | 1.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $8.9M | 284,000 | 1.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $8.8M | 700,000 | 1.1% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $8.4M | 206,000 | 1.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $8.3M | 88,000 | 1.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $7.5M | 1,000,000 | 0.9% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $7.3M | 62,000 | 0.9% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $7.1M | 174,000 | 0.9% |
| Lifestance Health Group Inc(LFST) | COM | 53228F101 | $7.1M | 773,000 | 0.9% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $7.0M | 80,000 | 0.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.6M | 72,000 | 0.8% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $6.3M | 250,000 | 0.8% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $6.2M | 250,000 | 0.8% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $6.1M | 227,000 | 0.8% |